Entity

Time filter

Source Type

Stillwater, OK, United States

Grant
Agency: Environmental Protection Agency | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 70.00K | Year: 2002

Concerns regarding the presence of endocrine disruptors in food, water, or other environmental media as well as concerns about the potential risk they pose to humans and wildlife have been growing in recent years. Passage in 1996 of the Food Quality Protection Act and Amendments to the Safe Drinking Water Act reflected these concerns and required the U.S. Environmental Protection Agency to develop a screening program, using appropriate validated test systems and other scientifically relevant information, to determine whether certain substances may have an endocrine effect in wildlife and humans. The proposed work will result in the validation of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research is to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown (GVBD) model as a system for the rapid evaluation of endocrine-disrupting chemicals (EDCs) found in the workplace or the environment. Specifically, Fort Environmental Laboratories, Inc., will validate and standardize a 24-hour X. laevis assay designed to evaluate progestin-active or antiprogestin EDCs in vitro by conducting an interlaboratory validation study with a series of known mammalian EDCs, compounds found to be inactive, and chemicals with unknown activity. Because none of the currently developed EDC screening systems are capable of specifically screening for progesterone-active EDCs, the successful completion of the in vitro oocyte GVBD model development will provide the scientific community with a nonmammalian, cost-effective, rapid, and reliable method of prescreening EDCs. The ability to rapidly and cost effectively screen for and evaluate the mechanisms of EDCs is an attractive alternative to the current laborious and expensive testing systems used today. Increasing concern over the widespread finding of EDCs in the environment has dramatically increased the need for standardized assays, such as the X. laevis GVBD model, because few other progestin/antiprogestin-based in vitro assays are available today.


Grant
Agency: Environmental Protection Agency | Branch: | Program: SBIR | Phase: Phase II | Award Amount: 225.00K | Year: 2002

Fort Environmental Laboratories, Inc.'s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown (GVBD) model as a system for the rapid evaluation of endocrine-disrupting chemicals (EDCs) found in the workplace or the environment. Specifically, a 24-hour X. laevis assay modified from the original work of Pickford and Morris (Environmental Health Perspectives 1999;107(4):285-292) and Lui and Patino (Biology of Reproduction 1993;49:980-988) designed to evaluate progestin-active or anti-progestin EDCs in vitro was standardized and evaluated by conducting a preliminary validation study with a series of known EDCs, compounds found to be inactive, and chemicals with unknown activity. The relative inhibitory potential of the toxicants study was ethinyl estradiol>>Aroclor 1260>atrazine>dieldrin. Testosterone and the confined animal feed operation (CAFO) waste complex mixture sample had a stimulatory effect on GVBD. Bisphenol A had no effect on GVBD, even at concentrations of 5,000 ¿M. The binding capacity of the toxicants to the oocyte membrane plasma receptor (OMPR) relative to progesterone was low. Interestingly, testosterone possessed some binding capacity to the OMPR, indicating that the OMPR may be a more precocious binding site than originally anticipated. However, the relative binding affinity of the toxicants to the OMPR was expressed as progesterone>>ethinyl estradiol (-)>testosterone (+)>atrazine (-)>Aroclor 1260 (-) >dieldrin (-)>CAFO sample (+)>bisphenol A (NE). The washout studies indicated that although the competitive binding affinity of ethinyl estradiol for the OMPR was the greatest of the test compounds evaluated in the present study, testosterone, dieldrin, and Aroclor 1260 were bound more tightly to the OMPR than ethinyl estradiol. Because none of the currently developed high throughput EDC screening systems are capable of specifically screening for progesterone-active EDCs, the successful completion of the in vitro oocyte GVBD model development will provide the scientific community with a non-mammalian, cost-effective, rapid, and reliable method of screening EDCs. The ability to rapidly and cost-effectively screen for and evaluate the mechanisms of EDCs is an attractive alternative to the current laborious and expensive testing systems used today. Increasing concerns over the widespread finding of EDCs in the environment have dramatically increased the need for standardized assays, such as the X. laevis GVBD model, because few other progestin/antiprogestin-based in vitro assays are available today.


Grant
Agency: Environmental Protection Agency | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 70.00K | Year: 2002

Fort Environmental Laboratories, Inc.¿s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown (GVBD) model as a system for the rapid evaluation of endocrine-disrupting chemicals (EDCs) found in the workplace or the environment. Specifically, a 24-hour X. laevis assay modified from the original work of Pickford and Morris (Environmental Health Perspectives 1999;107(4):285-292) and Lui and Patino (Biology of Reproduction 1993;49:980-988) designed to evaluate progestin-active or anti-progestin EDCs in vitro was standardized and evaluated by conducting a preliminary validation study with a series of known EDCs, compounds found to be inactive, and chemicals with unknown activity. The relative inhibitory potential of the toxicants study was ethinyl estradiol>>Aroclor 1260>atrazine>dieldrin. Testosterone and the confined animal feed operation (CAFO) waste complex mixture sample had a stimulatory effect on GVBD. Bisphenol A had no effect on GVBD, even at concentrations of 5,000 ¿M. The binding capacity of the toxicants to the oocyte membrane plasma receptor (OMPR) relative to progesterone was low. Interestingly, testosterone possessed some binding capacity to the OMPR, indicating that the OMPR may be a more precocious binding site than originally anticipated. However, the relative binding affinity of the toxicants to the OMPR was expressed as progesterone>>ethinyl estradiol (-)>testosterone (+)>atrazine (-)>Aroclor 1260 (-) >dieldrin (-)>CAFO sample (+)>bisphenol A (NE). The washout studies indicated that although the competitive binding affinity of ethinyl estradiol for the OMPR was the greatest of the test compounds evaluated in the present study, testosterone, dieldrin, and Aroclor 1260 were bound more tightly to the OMPR than ethinyl estradiol. Because none of the currently developed high throughput EDC screening systems are capable of specifically screening for progesterone-active EDCs, the successful completion of the in vitro oocyte GVBD model development will provide the scientific community with a non-mammalian, cost-effective, rapid, and reliable method of screening EDCs. The ability to rapidly and cost-effectively screen for and evaluate the mechanisms of EDCs is an attractive alternative to the current laborious and expensive testing systems used today. Increasing concerns over the widespread finding of EDCs in the environment have dramatically increased the need for standardized assays, such as the X. laevis GVBD model, because few other progestin/antiprogestin-based in vitro assays are available today.


Grant
Agency: Environmental Protection Agency | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 0.00 | Year: 2002

Fort Environmental Laboratories, Inc.'s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown (GVBD) model as a system for the rapid evaluation of endocrine-disrupting chemicals (EDCs) found in the workplace or the environment. Specifically, a 24-hour X. laevis assay modified from the original work of Pickford and Morris (Environmental Health Perspectives 1999;107(4):285-292) and Lui and Patino (Biology of Reproduction 1993;49:980-988) designed to evaluate progestin-active or anti-progestin EDCs in vitro was standardized and evaluated by conducting a preliminary validation study with a series of known EDCs, compounds found to be inactive, and chemicals with unknown activity. The relative inhibitory potential of the toxicants study was ethinyl estradiol>>Aroclor 1260>atrazine>dieldrin. Testosterone and the confined animal feed operation (CAFO) waste complex mixture sample had a stimulatory effect on GVBD. Bisphenol A had no effect on GVBD, even at concentrations of 5,000 ¿M. The binding capacity of the toxicants to the oocyte membrane plasma receptor (OMPR) relative to progesterone was low. Interestingly, testosterone possessed some binding capacity to the OMPR, indicating that the OMPR may be a more precocious binding site than originally anticipated. However, the relative binding affinity of the toxicants to the OMPR was expressed as progesterone>>ethinyl estradiol (-)>testosterone (+)>atrazine (-)>Aroclor 1260 (-) >dieldrin (-)>CAFO sample (+)>bisphenol A (NE). The washout studies indicated that although the competitive binding affinity of ethinyl estradiol for the OMPR was the greatest of the test compounds evaluated in the present study, testosterone, dieldrin, and Aroclor 1260 were bound more tightly to the OMPR than ethinyl estradiol. Because none of the currently developed high throughput EDC screening systems are capable of specifically screening for progesterone-active EDCs, the successful completion of the in vitro oocyte GVBD model development will provide the scientific community with a non-mammalian, cost-effective, rapid, and reliable method of screening EDCs. The ability to rapidly and cost-effectively screen for and evaluate the mechanisms of EDCs is an attractive alternative to the current laborious and expensive testing systems used today. Increasing concerns over the widespread finding of EDCs in the environment have dramatically increased the need for standardized assays, such as the X. laevis GVBD model, because few other progestin/antiprogestin-based in vitro assays are available today.


Grant
Agency: Environmental Protection Agency | Branch: | Program: SBIR | Phase: Phase I | Award Amount: 70.00K | Year: 2003

Concerns regarding both the presence of endocrine disruptors in food, water, or other environmental media as well as the potential risk they pose to humans and wildlife have been growing in recent years. Passage of the Food Quality Protection Act and Amendments to the Safe Drinking Water Act reflected these concerns and required the U.S. Environmental Protection Agency (EPA) to develop a screening program, using appropriate validated test systems and other scientifically relevant information, to determine whether certain substances may have an endocrine effect in wildlife and humans. This research project will result in the validation of an assay that tests substances that might disturb reproductive and developmental processes during the lifecycle of animals by interfering with the endocrine system. The primary goal of the proposed research is to standardize, validate, and commercialize an amphibian lifecycle model using Xenopus as a system for evaluation of endocrine-disrupting chemicals (EDCs) found in the workplace or the environment. Specifically, Fort Environmental Laboratories, Inc., will standardize and validate an X. tropicalis assay designed to evaluate the effect of EDCs on various aspects of the amphibian lifecycle by conducting studies with a series of known mammalian EDCs, compounds found to be inactive, and chemicals with unknown activity. Because none of the currently developed EDC test systems are capable of specifically addressing lifecycle effects in amphibians and the Endocrine Disruptor Screening Program developed for EPA by the Endocrine Screening and Testing Committee, the successful completion of this amphibian lifecycle model will provide the scientific community with a non-mammalian, cost-effective, rapid, reliable method of prescreening EDCs. The ability to rapidly and cost-effectively screen for and evaluate the mechanisms of EDCs is an attractive alternative to the current laborious and expensive testing systems used today. Increasing concerns over the widespread finding of EDCs in the environment have dramatically increased the need for standardized assays, such as the Xenopus lifecycle model, because no other assay of this type is available today. Current estimates indicate that nearly 50,000 chemicals in the United States may require EDC testing with models such as the amphibian lifecycle assay. Overall, this volume of work has the potential of generating approximately $125 billion during the next 10¿15 years. Realistically, it is anticipated that based on the high volume of work generated by this need for cost-effective testing of chemicals, revenue of more than $5 million could be generated during the next 2 years, and more than $25 billion during the next 10 years.

Discover hidden collaborations